Physician

Alan J Reinach, MD

According to 2025 Medicare claims, Alan Reinach, MD (NPI: 1477555324) practices pulmonary disease in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is HR PHYSICIAN SERVICES (NPI: 1992707962; TIN: 232696460) and primary practice location at 19046-8001. Reinach is affiliated with the Community Care Collaborative of Pennsylvania and New Jersey LLC (ACO ID: A3318), participating under the MSSP model.

Reinach's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 511 traditional Medicare patients, billed 1,151 HCPCS/CPT codes, and received $100,951 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,476 prescription claims across 298 beneficiaries totaling $643,378 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,643 claims. Open Payments data shows 33 records totaling $739. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $169,176 to $100,951. In contrast, Part D prescription costs have risen steadily, from $349,674 to $643,378. For DME billing, reported payments moved sharply higher in recent years, from $38,485 to $131,318.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$85K$169K2015 Medicare payment: $169,176 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $162,219 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $149,554 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $143,807 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $121,666 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $116,796 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $121,590 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $96,131 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $99,576 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $100,951 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156082,372$169,176
20166352,271$162,219
20176372,108$149,554
20186152,043$143,807
20195981,793$121,666
20205091,329$116,796
20215111,315$121,590
20225431,302$96,131
20235191,091$99,576
20245111,151$100,951

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$366K$731K2015 Drug cost: $349,674 (USD; Tot_Drug_Cst)2016 Drug cost: $372,339 (USD; Tot_Drug_Cst)2017 Drug cost: $406,041 (USD; Tot_Drug_Cst)2018 Drug cost: $396,299 (USD; Tot_Drug_Cst)2019 Drug cost: $499,982 (USD; Tot_Drug_Cst)2020 Drug cost: $484,612 (USD; Tot_Drug_Cst)2021 Drug cost: $434,369 (USD; Tot_Drug_Cst)2022 Drug cost: $547,886 (USD; Tot_Drug_Cst)2023 Drug cost: $731,167 (USD; Tot_Drug_Cst)2024 Drug cost: $643,378 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152031,084$349,674
20162021,051$372,339
20172131,111$406,041
20182081,147$396,299
20192271,263$499,982
20202161,095$484,612
20212031,049$434,369
20222281,116$547,886
20232871,381$731,167
20242981,476$643,378

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$62K$124K2015 Medicare payment: $35,892 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $40,774 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $34,802 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $36,968 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $46,043 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $75,039 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $61,301 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $75,431 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $93,343 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $124,131 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015158762$35,892
2016188965$40,774
2017253955$34,802
2018256992$36,968
2019264997$46,043
20202511,033$75,039
2021258942$61,301
20223201,073$75,431
20234791,402$93,343
20245291,643$124,131

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99291Critical care, first 30-74 minutes78179$171
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more197213$94
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes75121$63
94729Test to examine how well the lungs exchange gases6767$15
94060Test to measure expiratory airflow and volume changes before and after medication administration6767$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35116,290$337,576
Stiolto RespimatTiotropium Br/Olodaterol Hcl1063,900$60,058
Breo ElliptaFluticasone/Vilanterol964,200$53,925
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr612,820$42,271
Arnuity ElliptaFluticasone Furoate873,150$23,078

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0466Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)YN/R58$58,394
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY24192$13,360
A7030Full face mask used with positive airway pressure device, eachN45111$9,039
A7031Face mask interface, replacement for full face mask, eachN44104$8,849
A4604Tubing with integrated heating element for use with positive airway pressure deviceN72173$6,091

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.33$739GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alan J. Reinach, MD?

Tedicare shows public-source Medicare data for Alan J. Reinach, MD (NPI 1477555324), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan J. Reinach, MD have ACO affiliation data?

Alan J. Reinach, MD is shown with ACO affiliation data for Community Care Collaborative of Pennsylvania and New Jersey LLC (MSSP, ACO ID A3318).

What billing organization is linked to Alan J. Reinach, MD?

Alan J. Reinach, MD is linked to HR PHYSICIAN SERVICES (billing NPI 1992707962) in the available physician profile data.

Does Alan J. Reinach, MD have Open Payments data?

Alan J. Reinach, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.